| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Ryan Arthur F serves as a Director at REGN. Across recent SEC filings that breaks down to 0 buys and 490 sells. Those positions are worth an estimated $11.2M at current prices.
Historically, Ryan Arthur F's trades have earned a middling insider score of 54/100 across 38 rated trades. Over a 12-month horizon, 37.8% of those trades were profitable, with an average 12-month return of -2.1%.
The biggest single holding is REGN (~$11.2M) as Director. The recent filings there lean toward selling, a net 14,196 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $603.23 | $60,323.46 | -0.3% | |
| May 6, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 50,124 | $550.88 | $27,612,508.54 | -63.5% | |
| May 1, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $520.37 | $52,036.62 | -0.3% | |
| Apr 1, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 200 | $475.27 | $95,053.51 | -0.7% | |
| Nov 15, 2016 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 2,000 | $429.34 | $858,680.00 | -5.2% |